Payment overview · 2025
General Payments
$192.08
5 reported records · 4 companies
Healthcare provider profile · identity verified
Thomas K Sligh, MD
Allopathic & Osteopathic Physicians|Internal Medicine · VICKSBURG, MS · NPI 1811928005
Verified facts
What the public records show
CMS Open Payments records show Thomas K Sligh, MD received $192.08 in general payments during 2025 across 5 reported records.
Philips North America LLC accounted for 68.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 5 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 169 claims for Ozempic by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 109 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Philips North America LLC | Unresolved — no canonical attribution shown | $131.00 | 68.2% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $30.40 | 15.8% | 2 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $15.95 | 8.3% | 1 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $14.73 | 7.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $192.08 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| LM Undivided Normalized: lm undivided |
Device | Philips North America LLC | $131.00 | 1 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $30.40 | 2 | 2025 |
Source payment records
|
|||||
| PAXLOVID Normalized: paxlovid |
Drug | PFIZER INC. | $15.95 | 1 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $14.73 | 1 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $14.73 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 169 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
169 | 33 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
109 | 24 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 976 | 247 |
| Amlodipine Besylate | Amlodipine Besylate | 848 | 197 |
| Potassium Chloride | Potassium Chloride | 779 | 199 |
| Levothyroxine Sodium | Levothyroxine Sodium | 605 | 144 |
| Furosemide | Furosemide | 377 | 96 |
| Pantoprazole Sodium | Pantoprazole Sodium | 375 | 89 |
| Omeprazole | Omeprazole | 360 | 85 |
| Metformin Hcl | Metformin Hcl | 357 | 97 |
| Losartan Potassium | Losartan Potassium | 349 | 87 |
| Gabapentin | Gabapentin | 332 | 86 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 295 | 81 |
| Metoprolol Succinate | Metoprolol Succinate | 288 | 70 |
| Hydrochlorothiazide | Hydrochlorothiazide | 278 | 64 |
| Clopidogrel | Clopidogrel Bisulfate | 251 | 64 |
| Lisinopril | Lisinopril | 235 | 63 |
| Glimepiride | Glimepiride | 225 | 52 |
| Metoprolol Tartrate | Metoprolol Tartrate | 224 | 47 |
| Simvastatin | Simvastatin | 224 | 55 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 189 | 41 |
| Tamsulosin Hcl | Tamsulosin Hcl | 175 | 43 |
| Diclofenac Sodium | Diclofenac Sodium | 171 | 66 |
| Ozempic | Semaglutide | 169 | 33 |
| Pravastatin Sodium | Pravastatin Sodium | 167 | 41 |
| Meloxicam | Meloxicam | 165 | 44 |
| Zolpidem Tartrate | Zolpidem Tartrate | 164 | 29 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 158 | 40 |
| Escitalopram Oxalate | Escitalopram Oxalate | 142 | 37 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 138 | 30 |
| Famotidine | Famotidine | 135 | 31 |
| Carvedilol | Carvedilol | 127 | 36 |
| Nifedipine Er | Nifedipine | 126 | 32 |
| Atenolol | Atenolol | 123 | 31 |
| Fluticasone Propionate | Fluticasone Propionate | 123 | 41 |
| Tizanidine Hcl | Tizanidine Hcl | 117 | 28 |
| Januvia | Sitagliptin Phosphate | 115 | 31 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 114 | 25 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 114 | 28 |
| Allopurinol | Allopurinol | 112 | 30 |
| Eliquis | Apixaban | 109 | 24 |
| Sertraline Hcl | Sertraline Hcl | 105 | 22 |
| Clonidine Hcl | Clonidine Hcl | 96 | 22 |
| Hydralazine Hcl | Hydralazine Hcl | 94 | 24 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 94 | 32 |
| Alprazolam | Alprazolam | 92 | 20 |
| Farxiga | Dapagliflozin Propanediol | 90 | 20 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 90 | 20 |
| Spironolactone | Spironolactone | 82 | 24 |
| Jardiance | Empagliflozin | 81 | 20 |
| Trazodone Hcl | Trazodone Hcl | 78 | 20 |
| Baclofen | Baclofen | 77 | 25 |
| Ezetimibe | Ezetimibe | 77 | 18 |
| Linzess | Linaclotide | 75 | 16 |
| Ropinirole Hcl | Ropinirole Hcl | 71 | 12 |
| Memantine Hcl | Memantine Hcl | 70 | 11 |
| Pregabalin | Pregabalin | 70 | 17 |
| Warfarin Sodium | Warfarin Sodium | 69 | 12 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 67 | 15 |
| Citalopram Hbr | Citalopram Hydrobromide | 65 | 14 |
| Levetiracetam | Levetiracetam | 65 | 15 |
| Xarelto | Rivaroxaban | 65 | 12 |
| Doxycycline Hyclate | Doxycycline Hyclate | 64 | 44 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 64 | 28 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 63 | 54 |
| Clonazepam | Clonazepam | 61 | suppressed |
| Lovastatin | Lovastatin | 61 | 13 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 60 | 52 |
| Donepezil Hcl | Donepezil Hcl | 60 | 17 |
| Synthroid | Levothyroxine Sodium | 60 | 14 |
| Glipizide | Glipizide | 59 | 16 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 59 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 58 | 16 |
| Meclizine Hcl | Meclizine Hcl | 55 | 25 |
| Colchicine | Colchicine | 53 | 16 |
| Promethazine Hcl | Promethazine Hcl | 52 | 11 |
| Estradiol | Estradiol | 51 | 15 |
| Myrbetriq | Mirabegron | 51 | 17 |
| Celecoxib | Celecoxib | 50 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 48 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 47 | suppressed |
| Minoxidil | Minoxidil | 46 | suppressed |
| Ibuprofen | Ibuprofen | 45 | 19 |
| Benazepril Hcl | Benazepril Hcl | 44 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 42 | 11 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 42 | 18 |
| Azithromycin | Azithromycin | 41 | 35 |
| Buspirone Hcl | Buspirone Hcl | 41 | 11 |
| Glipizide Er | Glipizide | 41 | 11 |
| Mupirocin | Mupirocin | 41 | 22 |
| Valsartan | Valsartan | 41 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 40 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 38 | suppressed |
| Chlorthalidone | Chlorthalidone | 37 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 37 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 37 | 17 |
| Methylprednisolone | Methylprednisolone | 37 | 32 |
| Quetiapine Fumarate | Quetiapine Fumarate | 37 | suppressed |
| Topiramate | Topiramate | 37 | suppressed |
| Amoxicillin | Amoxicillin | 36 | 32 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 36 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 36 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 36 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 35 | 17 |
| Levofloxacin | Levofloxacin | 34 | 27 |
| Sucralfate | Sucralfate | 34 | suppressed |
| Fluconazole | Fluconazole | 33 | 20 |
| Montelukast Sodium | Montelukast Sodium | 33 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 33 | 11 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 32 | suppressed |
| Mounjaro | Tirzepatide | 31 | suppressed |
| Novolog Flexpen | Insulin Aspart | 31 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 30 | suppressed |
| Naproxen | Naproxen | 30 | 12 |
| Alendronate Sodium | Alendronate Sodium | 29 | suppressed |
| Prednisone | Prednisone | 29 | 12 |
| Doxepin Hcl | Doxepin Hcl | 28 | suppressed |
| Ketoconazole | Ketoconazole | 28 | 11 |
| Ondansetron Odt | Ondansetron | 28 | 19 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 28 | 11 |
| Nebivolol Hcl | Nebivolol Hcl | 27 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 27 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 26 | suppressed |
| Levemir Flexpen | Insulin Detemir | 26 | 13 |
| Sumatriptan Succinate | Sumatriptan Succinate | 25 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 24 | 17 |
| Lacosamide | Lacosamide | 24 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 24 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 24 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 24 | suppressed |
| Trulicity | Dulaglutide | 24 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 24 | 11 |
| Breo Ellipta | Fluticasone/Vilanterol | 23 | suppressed |
| Glyburide | Glyburide | 23 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 23 | suppressed |
| Mirtazapine | Mirtazapine | 23 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 22 | 19 |
| Nystatin | Nystatin | 22 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 22 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 22 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 21 | suppressed |
| Digoxin | Digoxin | 21 | suppressed |
| Felodipine Er | Felodipine | 21 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 21 | suppressed |
| Cilostazol | Cilostazol | 20 | suppressed |
| Diazepam | Diazepam | 20 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 20 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 20 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 19 | suppressed |
| Nitroglycerin | Nitroglycerin | 19 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 19 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 18 | suppressed |
| Gemtesa | Vibegron | 18 | suppressed |
| Insulin Lispro Protamine Mix | Insulin Lispro Protamin/Lispro | 18 | suppressed |
| Methimazole | Methimazole | 18 | suppressed |
| Methocarbamol | Methocarbamol | 18 | 11 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 18 | 16 |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Cephalexin | Cephalexin | 17 | 12 |
| Dexlansoprazole Dr | Dexlansoprazole | 17 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 17 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 17 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 17 | suppressed |
| Primidone | Primidone | 17 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 17 | suppressed |
| Bumetanide | Bumetanide | 16 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 16 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 16 | suppressed |
| Klor-Con M20 | Potassium Chloride | 16 | suppressed |
| Lamotrigine | Lamotrigine | 16 | suppressed |
| Ramipril | Ramipril | 16 | suppressed |
| Risperidone | Risperidone | 15 | suppressed |
| Aripiprazole | Aripiprazole | 14 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Temazepam | Temazepam | 14 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 13 | suppressed |
| Fenofibrate | Fenofibrate | 13 | suppressed |
| Humulin R U-500 Kwikpen | Insulin Regular, Human | 13 | suppressed |
| Irbesartan | Irbesartan | 13 | suppressed |
| Lubiprostone | Lubiprostone | 13 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 13 | suppressed |
| Tradjenta | Linagliptin | 13 | suppressed |
| Verapamil Er | Verapamil Hcl | 13 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 12 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 12 | suppressed |
| Latanoprost | Latanoprost | 12 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 12 | suppressed |
| Scopolamine | Scopolamine | 12 | suppressed |
| Acyclovir | Acyclovir | 11 | suppressed |
| Clonidine | Clonidine | 11 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 11 | suppressed |
| Klor-Con M10 | Potassium Chloride | 11 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Metolazone | Metolazone | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $192.08 · 5 records | Philips North America LLC | LM Undivided, Ozempic, PAXLOVID, Rybelsus, The Cologuard Plus Collection Kit | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error